22 August 2025 marked a milestone moment for the medical device industry in Southeast Asia, as the Medical Device Authority (MDA) and the...

As part of its ongoing efforts to streamline regulatory processes and ensure better clarity for applicants, the Health Sciences Authority...

As the digital health landscape continues to evolve rapidly, the Health Sciences Authority (HSA) released the Revision 2 (R2)  of its...

The Health Sciences Authority (HSA) has announced the implementation of revised GN-21, which is set to take effect on 14 July 2025 . This...

The Health Sciences Authority (HSA) is ushering in a new era for the medical device industry with the launch of the Singapore Health...

The Health Sciences Authority (HSA) launched a public consultation on a pivotal proposal that could significantly reshape the landscape...

The landscape of clinical research is constantly evolving, and with it, the standards that ensure trial integrity and participant safety...

The Health Sciences Authority (HSA) is set to roll out a significant update to its regulatory infrastructure with the Singapore Health...

The increasing integration of technology in healthcare has revolutionized patient care and introduced new cybersecurity challenges. As...